Merkel Cell Carcinoma Treatment MarketPosted by ahila on April 26th, 2018 Merkel Cell Carcinoma Treatment Market :Merkel cell carcinoma is an uncommon type of skin cancer and also known as neuroendocrine skin carcinoma or trabecular carcinoma. It occurs due to abnormal growth of Merkel cells. This cancer has grown and spreads rapidly beyond the skin. Merkel cells are the type of skin neuroendocrine cells as they share some features with hormone making and nerve cells. Merkel cells are found at the base of the epidermis, the top layer of the skin and are very close to nerve endings which helps us to sense touch and light. Increasing cases of Merkel cell carcinoma and rising demand for immunotherapy treatment are major factors, expected to drive the growth of the market. Furthermore, growing investments in R&D, developing healthcare infrastructure, are the factors which are propelling the growth of Merkel cell carcinoma treatment market. However, lack of nursing care, adverse effects associated with chemo and immunotherapy drugs, high cost associated with the medicines, restricted adequacy of the medication and stringent regulatory framework are expected to hamper the growth of MCC treatment market. A sample of this report is available upon request @ Based on drugs, the merkel cell carcinoma treatment market is segmented into the following
o Antimetabolites o Alkylating agents o Antibiotics o Taxanes o Topoisomerase inhibitors
Based on distribution channel, the merkel cell carcinoma treatment market is segmented into the following:
To view TOC of this report is available upon request @ Like it? Share it! More by this author |